cjc-1134-pc
Peptideexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
2
Phase 4
0
Earliest trial started Apr 16, 2021 (NCT07058545)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07057271 | Phase 3 | May 27, 2021 | ConjuChem Biotechnologies Inc., Peking University |
| NCT07058545 | Phase 3 | Apr 16, 2021 | ConjuChem Biotechnologies Inc., Peking University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ConjuChem Biotechnologies Inc. | For profit | 2 | 2 | 1 | 2021 |
| Peking University | Academic/Hospital | 2 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1